JAZZ Competitors & Alternatives
Compare Jazz Pharmaceuticals PLC with similar stocks in the same industry
Biotechnology
JAZZ
Main Stock$245.43
Tradestie Score
43
Market Cap
$8.30B
P/E Ratio
72.1
Revenue Growth
0.1%
Analyst Upside
+20.7%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
UTHR
United Therapeutics Corp
|
$588.61
|
$19.82B | 22.0 | 48 | Compare |
|
GMAB
Genmab A/S ADS
|
$54.07
|
$19.56B | 47.7 | 32 | Compare |
|
INCY
Incyte Genomics Inc
|
$120.30
|
$16.93B | 62.2 | 53 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$69.45
|
$15.70B | 44.9 | 43 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$17.83
|
$15.22B | - | 45 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$169.14
|
$13.59B | 24.4 | 28 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$256.55
|
$12.36B | 19.9 | 31 | Compare |
|
EXEL
Exelixis Inc
|
$70.58
|
$11.09B | 21.5 | 32 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$41.19
|
$10.76B | - | 43 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$250.83
|
$10.74B | - | 48 | Compare |
More JAZZ Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry